Literature DB >> 21258398

Cancer-related direct-to-consumer advertising: a critical review.

Emily Z Kontos1, K Viswanath.   

Abstract

The direct-to-consumer advertising (DTCA) phenomenon has received attention because of its attempt to reach out to consumers by bypassing important gatekeepers such as physicians. The emergence of new information platforms and the introduction of genetic tests directly to the consumer have heightened the concern with DTCA and its potential consequences. These effects of DTCA are particularly important given the communication inequalities among social groups, with class, race and ethnicity influencing how people access, seek, process and act on information. This Science and Society article reviews the major issues regarding general and cancer-related DTCA and also offers data from a national survey in the United States as an example of the communication inequalities in genetic testing awareness.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21258398     DOI: 10.1038/nrc2999

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  38 in total

1.  The educational value of consumer-targeted prescription drug print advertising.

Authors:  R A Bell; M S Wilkes; R L Kravitz
Journal:  J Fam Pract       Date:  2000-12       Impact factor: 0.493

Review 2.  The role of marketing in pharmaceutical research and development.

Authors:  John E Calfee
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

3.  Direct-to-consumer prescription drug advertising: history, regulation, and issues.

Authors:  Jisu Huh; Denise E DeLorme; Leonard N Reid; Soontae An
Journal:  Minn Med       Date:  2010-03

4.  Comprehension of information in three direct-to-consumer television prescription drug advertisements among adults with limited literacy.

Authors:  Kimberly A Kaphingst; Rima E Rudd; William Dejong; Lawren H Daltroy
Journal:  J Health Commun       Date:  2005 Oct-Nov

Review 5.  Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2005-09-06       Impact factor: 25.391

Review 6.  Science and society: the communications revolution and cancer control.

Authors:  K Viswanath
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

7.  Public awareness and use of direct-to-consumer genetic tests: results from 3 state population-based surveys, 2006.

Authors:  Katrina A B Goddard; Debra Duquette; Amy Zlot; Jenny Johnson; Ann Annis-Emeott; Patrick W Lee; Mary Pat Bland; Karen L Edwards; Kristin Oehlke; Rebecca T Giles; Ann Rafferty; Michelle L Cook; Muin J Khoury
Journal:  Am J Public Health       Date:  2008-12-23       Impact factor: 9.308

Review 8.  The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues.

Authors:  Stuart Hogarth; Gail Javitt; David Melzer
Journal:  Annu Rev Genomics Hum Genet       Date:  2008       Impact factor: 8.929

9.  Direct-to-consumer prescription drug advertising, 1989-1998. A content analysis of conditions, targets, inducements, and appeals.

Authors:  R A Bell; R L Kravitz; M S Wilkes
Journal:  J Fam Pract       Date:  2000-04       Impact factor: 0.493

10.  Re: "Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally occurring experiment".

Authors:  Marc S Williams
Journal:  Genet Med       Date:  2005-09       Impact factor: 8.822

View more
  20 in total

1.  Update on Direct-to-Consumer Marketing in Oncology.

Authors:  Stacy W Gray; Gregory A Abel
Journal:  J Oncol Pract       Date:  2012-02-21       Impact factor: 3.840

2.  The social group influences of US health journalists and their impact on the newsmaking process.

Authors:  M P McCauley; K D Blake; H I Meissner; K Viswanath
Journal:  Health Educ Res       Date:  2012-08-20

3.  Health care information in African American churches.

Authors:  Brook E Harmon; Sei-Hill Kim; Christine E Blake; James R Hébert
Journal:  J Health Care Poor Underserved       Date:  2014-02

4.  Quantitative Information on Oncology Prescription Drug Websites.

Authors:  Helen W Sullivan; Kathryn J Aikin; Linda B Squiers
Journal:  J Cancer Educ       Date:  2018-04       Impact factor: 2.037

5.  Potential spillover educational effects of cancer-related direct-to-consumer advertising on cancer patients' increased information seeking behaviors: results from a cohort study.

Authors:  Andy S L Tan
Journal:  J Cancer Educ       Date:  2014-06       Impact factor: 2.037

6.  A Study of the Frequency and Social Determinants of Exposure to Cancer-Related Direct-to-Consumer Advertising Among Breast, Prostate, and Colorectal Cancer Patients.

Authors:  Andy S L Tan
Journal:  Health Commun       Date:  2014-10-30

7.  The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations.

Authors:  S W Gray; R C Hornik; J S Schwartz; K Armstrong
Journal:  Clin Genet       Date:  2011-11-02       Impact factor: 4.438

Review 8.  The communications revolution and health inequalities in the 21st century: implications for cancer control.

Authors:  K Viswanath; Rebekah H Nagler; Cabral A Bigman-Galimore; Michael P McCauley; Minsoo Jung; Shoba Ramanadhan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10       Impact factor: 4.254

9.  Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 National Health Interview Surveys.

Authors:  Phuong L Mai; Susan Thomas Vadaparampil; Nancy Breen; Timothy S McNeel; Louise Wideroff; Barry I Graubard
Journal:  Am J Prev Med       Date:  2014-05       Impact factor: 5.043

10.  Outcomes of genetic evaluation for hereditary cancer syndromes in unaffected individuals.

Authors:  Shanna L Gustafson; Victoria M Raymond; Monica L Marvin; Tobias Else; Erika Koeppe; Elena M Stoffel; Jessica N Everett
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.